Tardive Dysphoria With Selective-Serotonin Reuptake Inhibitors Treated Successfully With Atypical Antidepressants: A Case Series From Tertiary Hospital Setting

Cureus. 2024 Mar 22;16(3):e56684. doi: 10.7759/cureus.56684. eCollection 2024 Mar.

Abstract

Tardive dysphoria (TDp) is a phenomenon characterized by the delayed onset or worsening of depressive symptoms following the discontinuation or alteration of antidepressant medications. TDp is a recently defined, under-recognized, and understudied condition. We present a series of five TDp cases exploring the diverse presentations, management strategies, and associated medical conditions. In all the cases, TDp manifested after prolonged use of selective serotonin reuptake inhibitors (SSRIs). All cases were successfully managed with atypical antidepressants. These cases offer insight into TDp, providing clinicians and researchers with examples of atypical trajectories in depressive symptomatology.

Keywords: antidepressant; mood disorders; selective serotonin reuptake inhibitors; tardive dysphoria; treatment-resistant depression.

Publication types

  • Case Reports

Grants and funding

The medical writing support was funded by Lupin Limited, India.